Rivastigmine tartrate

Corey-Bloom J, Anand R, Veach J, for the ENA 713 B352 Study Group (1998). A randomised trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild and moderately severe Alzheimer s disease. IntJGeriatrPsychopharmacolX, 55-65. [Pg.86]

Cholinesterase inhibitors donepezil hydrochloride galantamine hydrobromide rivastigmine tartrate... [Pg.617]

Exelon oral solution is supplied as a solution containing rivastigmine tartrate, equivalent to 2 mg/mL rivastigmine base for oral administration. Inactive ingredients are citric... [Pg.184]

Canitano R, Scandurra V (2008) Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatr Dis Treat 4 723-730 Carlson NR (2001) Physiology of behavior. Allyn and Bacon, Boston, MA Chez MG, Aimonovitch M, Buchanan T, Mrazek S, Tremb RJ (2004) Treating autistic spectrum disorders in children utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol 19 165-169... [Pg.392]

Rivastigmine tartrate (exelon) (2000) (40)Galantamine liydrobromide (reminyl) (2001) Figure 13.10. Approved acetylcholine esterase inhibitors. [Pg.762]

Novartis Pharmaceuticals. Exelon (rivastigmine tartrate) package insert. East Hanover, NJ, 2001. [Pg.1173]

Chez MG, Aimonovitch M, Buchanan T, Meazek S, Tremb RJ (2004) Treating autistic spectrum disorders in children utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol 19 165-169. [Pg.154]

RIVASTIGMINE TARTRATE (Exelon capsules 1.5 mg (as base), capsules 3 mg (as base), capsules 4.5 mg (as base), capsules 6 mg (as base), solution 2 mg/mL (as base))... [Pg.626]

Exelon (Rivastigmine tartrate). Novartis Pharmaceuticals Corp. US Prescribing information, June 2006. [Pg.353]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...